How Mark Kinney Champions Independent Pharmacy
You have been with IPC for several years now. Can you take us back to when you first joined and share what drew you to IPC and the mission at that time?
When I joined IPC nearly 20 years ago, the organization made a very intentional decision. IPC wanted a stronger voice and a more active role in advocating for independent pharmacies. At the time, the focus was primarily federal, but over the years that commitment has expanded significantly. Today, IPC has a government relations presence in all 50 states, which speaks to how seriously we take advocacy on behalf of our members.
As Executive Vice President of Government Relations, what personally motivates you about advocating for independent pharmacy owners and their patients?
I am deeply passionate about the role independent pharmacies play in their communities. These pharmacies are not just places where medications are dispensed. They are community anchors. In many cases, families have been going to the same pharmacy for generations, not just for healthcare needs, but for guidance, reassurance, and trust. That level of connection is something you simply do not see everywhere, and it is what truly sets independent pharmacies apart.
You are also a licensed pharmacist. How does that background shape the way you support IPC members?
I am still a licensed pharmacist, although I have not been behind the counter for about 30 years. I started my career as a consultant pharmacist, working in long term care facilities and collaborating closely with physicians on drug therapy decisions. That clinical background gives me a strong understanding of what pharmacists face day to day. It helps me advocate more effectively because I know firsthand the challenges, responsibilities, and realities of the profession.
Government Relations work can feel very behind the scenes. What does your team do to support IPC members, and how does that work show up in pharmacies?
Our team works year-round to build and maintain relationships with elected officials and regulatory agencies. We also collaborate closely with national and state pharmacy associations to deliver a consistent and unified message. Over time, IPC has become a trusted resource for policymakers who rely on us for accurate data and insight on issues like PBM reform, provider status, compounding, and 340B. That behind the scenes work translates into real protections, better reimbursement, and expanded opportunities for pharmacies on the ground.
IRA medications are top of mind for pharmacists right now. What are you hearing from members, and how has the Government Relations team been supporting them?
IPC met twice with CMS over the past year to ensure they understood how IRA implementation would impact independent pharmacies and Medicare beneficiaries. That early engagement was critical. So far, members are telling us the program is functioning relatively well, but there are two major concerns. The first is adequate reimbursement, which appears to be addressed in most cases. The second, and bigger concern, is cash flow. Pharmacies often must pay wholesalers within about 17 days, while reimbursement can take 21 days or longer. We are closely monitoring this gap and staying in constant communication with members. Early indicators suggest payments are starting to flow, and we are hopeful this program may ultimately create opportunities rather than setbacks.
Can you share a recent win that reinforces why this work matters for independent pharmacy?
One of the most significant recent wins was passing commercial reimbursement floor laws in Iowa, Montana and Colorado. These laws i are expected to result in tens of millions of dollars in additional reimbursement for independent pharmacies across the state. That kind of impact is exactly why this work matters.
How do IPC’s Government Relations efforts influence broader industry conversations beyond our membership?
We are increasingly involved in discussions with pharmaceutical manufacturers about improving access to medications and patient adherence. There is a well-known drop off between prescriptions written and prescriptions filled, and manufacturers recognize that community pharmacies play a critical role in addressing that gap. These conversations position independent pharmacies as essential partners in improving outcomes, which benefit patients, pharmacies, and the healthcare system.
Looking ahead to 2026, what should pharmacy owners be paying close attention to, and how is your team preparing?
Each year, IPC convenes experts from across the country to identify emerging legislative and policy issues. Looking ahead, PBM reform, provider status, payment for clinical services, compounding protections, and 340B remain top priorities. We are seeing strong momentum around allowing pharmacists to practice at the top of their license, which is especially important given the growing physician shortage. Our team is preparing by staying proactive, engaging early with policymakers, and ensuring IPC members have advocates on the ground where it matters most.
Outside of work, how do you like to recharge?
My wife and I love world travel. Over the years, we have been fortunate to visit places like Croatia, Greece, New Zealand, and even Antarctica. We enjoy experiencing new cultures and seeing parts of the world that feel truly different. Closer to home, my family and I have also taken up pickleball, which has been a fun way to stay active and unplug, even if only for a little while.
